Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke

被引:11
|
作者
Kasemsap, Narongrit [1 ,2 ]
Vorasoot, Nisa [1 ,2 ]
Kongbunkiat, Kannikar [1 ,2 ]
Peansukwech, Udomlack [1 ]
Tiamkao, Somsak [1 ,2 ]
Sawanyawisuth, Kittisak [1 ,2 ,3 ,4 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Med, 123 Mitraparp Highway, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, North Eastern Stroke Res Grp, Khon Kaen, Thailand
[3] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand
[4] Khon Kaen Univ, Internal Med Res Grp, Khon Kaen, Thailand
来源
NEUROPSYCHIATRIC DISEASE AND TREATMENT | 2018年 / 14卷
关键词
acute ischemic stroke; length of stay; thrombolysis; TISSUE-PLASMINOGEN ACTIVATOR; OF-STAY; ATRIAL-FIBRILLATION; MEDICAL COMPLICATIONS; NATIONAL DATA; OUTCOMES; MORTALITY; NETHERLANDS; PREDICTOR; PNEUMONIA;
D O I
10.2147/NDT.S151836
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There are limited data available on factors associated with length of stay (LOS) in cases of acute ischemic stroke according to Poisson analysis, which is more appropriate than other methods. Materials and methods: We retrospectively reviewed medical summary charts of patients with acute ischemic stroke in 30 hospitals across northeast Thailand, with the main outcome as LOS. Poisson regression was used to examine factors associated with LOS. Results: We included 898 patients in the analysis; 460 (51.2%) were male. The median age (interquartile; IQR) was 58 (67-75) years and the median LOS was 5 (4-7) days. The median National Institute of Health Stroke Scale (NIHSS [IQR]) was 8 (4-13). Results of the analysis showed that, after controlling for age, stroke severity, atrial fibrillation, and thrombolytic use, significant variables associated with LOS were moderate stroke (incidence rate ratio [IRR] 95% confidence interval [CI] = 1.15 [range 1.01-1.30], P = 0.040), severe stroke (IRR [95% CI] = 1.27 [1.09-1.47], P = 0.002), thrombolytic use (IRR [95% CI] = 0.68 [0.60-0.76], P > 0.001), and atrial fibrillation (IRR [95% CI] = 1.15 [1.02-1.30], P = 0.023). After adjusting for complications, thrombolytic use remained significantly associated with decreased LOS (IRR [95% CI] = 0.74 [0.67-0.83], P = 0.001). Other significant factors were atrial fibrillation (IRR [95% CI] = 1.14 [1.02-1.28], P = 0.018), pneumonia (IRR [95% CI] = 1.48 [1.30-1.68], P < 0.001), and urinary tract infection (IRR [95% CI] = 1.41 [1.14-1.74], P = 0.001). Conclusion: According to Poisson analysis, intravenous thrombolysis, atrial fibrillation, pneumonia, and urinary tract infection are associated with LOS in cases of acute ischemic stroke, regardless of age, stroke severity, comorbidities, or complications.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 50 条
  • [1] Exploring the impact of intravenous thrombolysis on length of stay for acute ischemic stroke: a retrospective cohort study
    Hung, Ling-Chien
    Hu, Ya-Han
    Sung, Sheng-Feng
    BMC HEALTH SERVICES RESEARCH, 2015, 15
  • [2] Exploring the impact of intravenous thrombolysis on length of stay for acute ischemic stroke: a retrospective cohort study
    Ling-Chien Hung
    Ya-Han Hu
    Sheng-Feng Sung
    BMC Health Services Research, 15
  • [3] Intravenous thrombolysis for acute ischemic stroke in Asia
    Sharma, Vijay K.
    Ng, Kay W. P.
    Venketasubramanian, Narayanaswamy
    Teoh, Hock L.
    Chan, Bernard P. L.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (02) : 209 - 217
  • [4] Intravenous thrombolysis for acute ischemic stroke
    Turc, G.
    Isabel, C.
    Calvet, D.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2014, 95 (12) : 1129 - 1133
  • [5] Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke
    Sarikaya, Hakan
    Arnold, Marcel
    Engelter, Stefan T.
    Lyrer, Philippe A.
    Michel, Patrik
    Odier, Celine
    Weder, Bruno
    Tettenborn, Barbara
    Mueller, Felix
    Sekoranja, Lucka
    Sztajzel, Roman
    Ballinari, Pietro
    Mattle, Heinrich P.
    Baumgartner, Ralf W.
    STROKE, 2011, 42 (07) : 1967 - 1970
  • [6] Intravenous thrombolysis for acute ischemic stroke: why not?
    Psychogios, Klearchos
    Tsivgoulis, Georgios
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (01) : 10 - 17
  • [7] Hospital-based management of acute ischemic stroke following intravenous thrombolysis
    Ossi, Raid G.
    Meschia, James F.
    Barrett, Kevin M.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (04) : 463 - 472
  • [8] Chinese neurologists' perspective on intravenous thrombolysis for acute ischemic stroke
    Wang, Meng-Die
    Yin, Xiao-Xv
    Yang, Ting-Ting
    Wang, Yong
    Zhu, Yi-Yi
    Zhou, Yan-Feng
    Lu, Zu-Xun
    Hu, Bo
    BRAIN AND BEHAVIOR, 2018, 8 (01):
  • [9] Current status of intravenous thrombolysis for acute ischemic stroke in Asia
    Sharma, Vijay K.
    Ng, Kay W. P.
    Venketasubramanian, Narayanaswamy
    Saqqur, Maher
    Teoh, Hock L.
    Kaul, Subash
    Srivastava, Padma M. V.
    Sergentanis, Theodoris
    Suwanwela, Nijasri
    Nguyen, Thang H.
    Wong, K. S. Lawrence
    Chan, Bernard P. L.
    INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (06) : 523 - 530
  • [10] Current and Future Use of Intravenous Thrombolysis for Acute Ischemic Stroke
    Elijovich, Lucas
    Chong, Ji Y.
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (05) : 316 - 321